California State Teachers Retirement System Biotechnology

California State Teachers Retirement System

$78.8 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
TNGX Tango Therapeutics, Inc.	$595M	$4,000 0.0% of portfolio	3,457	Q1 2025 Reduced 92.32%
THRD Third Harmonic Bio, Inc.	$217M	$4,000 0.0% of portfolio	1,437	Q2 2024 Reduced 26.65%
APLT Applied Therapeutics Inc.	$21.1M	$3,000 0.0% of portfolio	6,966	Q1 2025 Reduced 90.23%
LXRX Lexicon Pharmaceuticals, Inc.	$200M	$3,000 0.0% of portfolio	8,319	Q1 2025 Reduced 95.74%
STRO Sutro Biopharma, Inc.	$40.7M	$3,000 0.0% of portfolio	5,932	Q2 2024 Reduced 3.14%
INZY Inozyme Pharma, Inc.	$161M	$3,000 0.0% of portfolio	3,746	Q2 2024 Reduced 21.94%
ABOS Acumen Pharmaceuticals, Inc.	$51M	$3,000 0.0% of portfolio	3,039	Q2 2024 New
PYXS Pyxis Oncology, Inc.	$36.5M	$3,000 0.0% of portfolio	3,539	Q2 2024 New
HLVX Hille Vax, Inc.	$69.5M	$3,000 0.0% of portfolio	2,284	Q2 2024 Added 792.64%
NAUT Nautilus Biotechnology, Inc.	$88.5M	$3,000 0.0% of portfolio	3,530	Q2 2024 Reduced 30.44%
ATNM Actinium Pharmaceuticals, Inc.	$38M	$3,000 0.0% of portfolio	2,178	Q2 2024 Reduced 21.82%
TCRX T Scan Therapeutics, Inc.	$31.6M	$3,000 0.0% of portfolio	2,782	Q2 2024 New
MRSN Mersana Therapeutics, Inc.	$590M	$2,000 0.0% of portfolio	8,220	Q2 2024 Reduced 26.24%
RAPT Rapt Therapeutics, Inc.	$323M	$2,000 0.0% of portfolio	2,174	Q2 2024 Reduced 90.57%
XFOR X4 Pharmaceuticals, Inc	$177M	$2,000 0.0% of portfolio	12,176	Q2 2024 Reduced 3.31%
STTK Shattuck Labs, Inc.	$32.2M	$2,000 0.0% of portfolio	2,834	Q2 2024 New
HOWL Werewolf Therapeutics, Inc.	$35.4M	$2,000 0.0% of portfolio	2,209	Q2 2024 New
AVTE Aerovate Therapeutics, Inc.	$65.5M	$2,000 0.0% of portfolio	977	Q2 2024 Reduced 13.08%
TNYA Tenaya Therapeutics, Inc.	$31.4M	$2,000 0.0% of portfolio	3,997	Q2 2024 Reduced 14.43%
GALT Galectin Therapeutics Inc	$224M	$1,000 0.0% of portfolio	1,476	Q2 2024 New
IGMS Igm Biosciences, Inc.	$37.7M	$1,000 0.0% of portfolio	1,099	Q2 2024 Reduced 17.74%
OVID Ovid Therapeutics Inc.	$38.7M	$1,000 0.0% of portfolio	4,267	Q2 2024 Reduced 28.82%
ALXO Alx Oncology Holdings Inc	$25.3M	$1,000 0.0% of portfolio	2,393	Q2 2024 Added 955.33%
GBIO Generation Bio Co.	$239M	$1,000 0.0% of portfolio	3,585	Q2 2024 Reduced 21.26%
IPSC Century Therapeutics, Inc.	$30.6M	$1,000 0.0% of portfolio	3,324	Q2 2024 Added 41.15%
PEPG Pep Gen Inc.	$28.8M	$1,000 0.0% of portfolio	1,126	Q2 2024 Added 11.49%
LYRA Lyra Therapeutics, Inc.	$215M	$0 0.0% of portfolio	3,507	Q2 2024 New
PRLD Prelude Therapeutics Inc	$30.6M	$0 0.0% of portfolio	955	Q2 2024 Reduced 36.16%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	36,988	Q2 2024 Reduced 7.31%
ELEV Elevation Oncology, Inc.	$8.39M	$0 0.0% of portfolio	3,780	Q2 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.